NAD+
Study design
22 women, ages 52 to 65, average age 60. Split-face, placebo-controlled — each woman's own face was the control. Twice daily for 42 days. Wrinkle depth measured by 3D imaging.
Crow's feet wrinkle depth down 9.2% at 4 weeks and 15.3% at 6 weeks
Measured skin age 4.9 years younger at 4 weeks and 8.2 years at 6 weeks, against a reference database of more than 300 women aged 30 to 65
Jowl line measurably lifted versus placebo, where the placebo side drifted the other way
Smoothness significantly improved at both 4 and 6 weeks
Separate 28-day study, 24 women ages 46 to 63: area and darkness of dark spots both significantly reduced at 4 weeks




